Peter Cloetens, ESRF scientist, during the experiments at the European...
Peter Cloetens, ESRF scientist, during the experiments at the European synchrotron ID16A beamline. The technique called nano- and micro X-ray phase-contrast tomography (XPCT), used at the ESRF, is a powerful tool to study structural and morphological alterations in the gut, without tissue manipulation.

Image credit: ESRF/Stef Candé

News • Role of the microbiome

Alzheimer's: X-rays unveil gut-brain connection

Scientists led by the Institute of Nanotechnology in Italy, in collaboration with the ESRF, the European Synchrotron in Grenoble, France, have discovered how X-ray micro- and nano- tomography can provide clues on the processes that link the gut neurons with those in the brain and may trigger Alzheimer’s.

The results are published in Science Advances

Alzheimer’s disease, the most common type of dementia, is a neurodegenerative disorder characterized by brain alteration including synaptic loss, chronic inflammation and neuronal cell death. In recent years, scientists have found evidence that the gut and the brain communicate through the neurons placed in both organs. Dysfunction in this axis has been linked to psychiatric and neurological disorders, including Alzheimer’s.

This technique represents a real breakthrough for the thorough analysis of the gut, and it could be pivotal in early detection and prognosis of [Alzheimer's] disease

Alessia Cedola

The gut microbiota, which refers to the microorganisms in the intestinal tract, plays a key role in human health and influences brain function, cognition and behaviour. “There are already many studies that support that changes in the gut composition can contribute to Alzheimer’s onset and progression”, explains Alessia Cedola, researcher from the Institute of Nanotechnology in Italy and corresponding author of the article. In particular, dysbiosis, which is the process by which there is a loss of microbial diversity, induces the prevalence of dangerous bacteria producing toxic metabolites promoting inflammation, and, consequently, the breakage of the gut/brain barriers. 

What happens exactly when gut dysbiosis occurs? “The main hypothesis is that changes trigger the escape of bad bacteria from the gut, entering the circulation, reaching the brain and triggering Alzheimer’s, but evidence is still poor”, adds Cedola. 

Now scientists have discovered that nano- and micro X-ray phase-contrast tomography (XPCT) is a powerful tool to study structural and morphological alterations in the gut, without tissue manipulation. The team came to the ESRF, the European Synchrotron, in Grenoble, France, to scan samples on beamline ID16A. “Thanks to this technique we can image soft biological tissues with excellent sensitivity in 3D, with minimal sample preparation and without contrast agents”, explains Peter Cloetens, scientist in charge of ID16A and co-author of the publication.

Representative 3d rendering of the longitudinal view of one crypt of SAMR1...
Representative 3d rendering of the longitudinal view of one crypt of SAMR1 mouse. the epithelial layer of the crypt has been rendered in green. the Paneth cells are colored in yellow and the goblet cells in blue. Scale bars, 5 μm. (B) and (C) show 3d renderings and nano-XPct close-ups of goblet and Paneth cells, respectively. the same color code of (A) has been used for the 3d renderings shown in (B) and (c). in detail, the goblet cell nucleus is colored in dark blue and the apical portion, expanded with mucin-secreting granules, which extends into the intestinal lumen, is rendered in light blue. the Paneth cell presents the typical pyramidal shape with basally situated nucleus (blue) and prominent apical granules (yellow) that occupy most of its cytoplasmatic region. nano-XPct close-ups in (B) show goblet cells (indicated by arrows) secreting mucus (asterisks) in the intestinal lumen. Scale bars, 2.5 μm. in (c), transversal view of a crypt in which the Paneth cells are arranged in a radial pattern (highlighted by the dashed-line boxes). the release of the antimicrobial granules (black dots, asterisk) into the lumen is visible. Scale bars, 5 μm.

Image source: Palermo F et al., Science Advances 2025 (CC BY 4.0)

The data of the experiments, partially carried out also at Soleil, showed the changes in cell abundance and organisation in the tissues, as well as structural alteration in different tissues of mice affected with Alzheimer’s. Specifically, it showed relevant alterations in the villi and crypts of the gut, cellular transformations in Paneth and goblet cells, along with the detection of telocytes, neurons, erythrocytes, and mucus secretion by goblet cells within the gut cavity. All these elements, when working correctly, maintain gut health, support digestion, and protect the intestinal lining from damage. 

“This technique represents a real breakthrough for the thorough analysis of the gut, and it could be pivotal in early detection and prognosis of the disease”, says Cedola. And she adds: “As a long-time user of the ESRF, I can attest to the incredible opportunities that this facility provides for cutting-edge research, and the nanoimaging beamline, especially with the EBS. Coming to the ESRF has been instrumental in advancing our understanding of the gut-brain axis in Alzheimer's disease”. 

Together with scientists Francesca Palermo and Claudia Balducci, the next steps in this research will be to further exploit the capabilities of XPCT to study how the gut communicates with the central nervous system. The team aims to investigate the enteric nervous system and its role in Alzheimer's disease. “By gaining a deeper understanding of these processes, we hope to identify new therapeutic targets and develop innovative treatments for this devastating disease. The ESRF will undoubtedly continue to play a crucial role in our research, and we look forward to many more exciting discoveries in the years to come”, concludes Cedola. 

This research highlights the importance of biomedical studies at the ESRF, as the facility aims to further enhance this focus in the coming years. 


Source: European Synchrotron Radiation Facility

03.02.2025

Related articles

Photo

News • Focus on Toxoplasma gondii

Could brain parasites help treat cognitive disorders?

Toxoplasma gondii is a parasite with the ability to infect the brain, causing life-threatening diseases. Researchers now want to harness its properties to advance treatment of cognitive disorders.

Photo

News • From silent to destructive

Exploring the two phases of Alzheimer's disease

Alzheimer’s disease may damage the brain in two distinct phases, based on new research funded by the National Institutes of Health (NIH) using sophisticated brain mapping tools.

Photo

News • Neurodegenerative diseases

Tauopathy or Alzheimer's? Biomarker and PET imaging for improved diagnosis

Researchers have identified biomarkers that, in conjunction with PET imaging, enable doctors to reliably distinguish between primary 4-repeat tauopathies and Alzheimer's disease.

Related products

Subscribe to Newsletter